| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
5,000 | 2,840 | 5,341 | - | - | - | |
Revenue | ||||||
- | - | - | 8,384 | 4,312 | 5,150 | |
Operating expenses: | ||||||
Research and development | ||||||
52,319 | 50,312 | 53,654 | 33,959 | 22,524 | 16,744 | |
General and administrative | ||||||
13,835 | 15,710 | 11,660 | 11,880 | 6,322 | 4,089 | |
Total operating expenses | ||||||
66,154 | 66,022 | 65,314 | 45,839 | 28,846 | 20,833 | |
Loss from operations | ||||||
-61,154 | -63,182 | -59,973 | -37,455 | -24,534 | -15,683 | |
Interest income | ||||||
1,093 | 872 | 641 | 246 | - | 1 | |
Interest expense | ||||||
- | - | - | - | 599 | 199 | |
Other income, net | ||||||
936 | 478 | -100 | -23 | 93 | 109 | |
Net loss | ||||||
-59,125 | -61,832 | -59,432 | -37,232 | -25,040 | -15,772 | |
Accruing dividends on preferred stock | ||||||
- | - | - | 1,378 | 9,724 | 7,837 | |
Net loss attributable to common stockholders | ||||||
- | - | - | -38,610 | -23,309 | -29,646 | |
Net loss per share—basic and diluted | ||||||
-1.16 | -1.61 | -2.34 | -2.06 | -42.14 | -63.74 | |
Weighted average common shares outstanding—basic and diluted | ||||||
51,139 | 38,495 | 25,407 | 18,759 | 553 | 465 | |
Other comprehensive income: | ||||||
Unrealized gain on investments | ||||||
6 | 3 | - | - | - | - | |
Comprehensive loss | ||||||
-59,119 | -61,829 | - | - | - | - | |